Freedom of Information request on whether Nardil 15 mg film-coated Tablets (PL 45043/0057) is authorised for use in the UK to Neon Healthcare Limited. (FOI 22/056)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-31-january-2022/freedom-of-information-request-on-whether-nardil-15-mg-film-coated-tablets-pl-450430057-is-authorised-for-use-in-the-uk-to-neon-healthcare-limited
FOI 22/056
3rd February 2022
Dear,
Thank you for your email.
In regards to you first question Nardil 15 mg film-coated Tablets (PL 45043/0057) is authorised for use in the UK to Neon Healthcare Limited.
Regarding the second question, as MHRA is the UK regulatory authority, we grant marketing authorisations to medicinal products for use in specific indications. Any further recommendations, advice or permissions would not be part of MHRA’s remit. We recommend that you contact Department of Health and Social Care (DHSC) for any further advice on question 2.
Web contact form - https://contactus.dh.gov.uk/?openform
If you have any queries, please reply to this email.
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: info@mhra.gov.uk
Due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices
Please remember to quote the reference number above in any future communications.
If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:
Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Yours sincerely
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000